Abstract:Objective: The objective of this study was to assess left atrial (LA) function with two-dimensional speckle tracking echocardiography (2DSTE) in addition to standard echocardiographic assessments in patients with hypertrophic obstructive cardiomyopathy (HOCM) before and 1 year after septal ablation (SA).Methods: The study included 31 patients with HOCM, who underwent SA. Each patient with HOCM underwent a complete two-dimensional transthoracic echocardiography before and 1 year after the SA. The measurements included basal septal thickness, left ventricular outflow trace (LVOT) gradient, mitral regurgitation (MR) grade, LA dimensions, left ventricular (LV) ejection fraction, and tissue Doppler parameters of lateral mitral annular e' and septal mitral annular e'. The LA wall was tracked on a frame-by-frame basis using 2DSTE, and LA volume waveforms were generated. The maximum LA volume (LAV(max)), minimal LA volume (LAV(min)), and the LA volume before atrial contraction (LAV(pre-a)) were measured. The LA reservoir function was calculated as the expansion index and diastolic emptying index. The LA conduit function was calculated as the passive emptying percentage of total emptying (PE) and the passive emptying index (PEI). The LA booster function was calculated as the active emptying percentage of total emptying (AE) and the active emptying index (AEI).Results: The LVOT gradient, end-diastolic septal base thickness, the grade of MR, and LA end-diastolic size were significantly decreased in patients with HOCM before and 1 year after the SA (All P<.05). The lateral mitral annular e' was significantly increased (P<.05), and the E/lateral e' ratio was significantly decreased (P<.05), whereas septal mitral annular e' was significantly decreased (P<.05), and the E/septal e' ratio was significantly increased (P<.05). LAVI(max), LAVI(min), and LAVI(pre-a) were significantly decreased 1 year after the SA (All P<.05). The expansion and diastolic emptying indices were significantly increased (All P<.05) at 1 year after the SA. PE and PEI were significantly increased (All P<.05). The AE and AEI were significantly decreased (All P<.05). LAVImax, LAVImin, and LAVIpre-a of the responders group were significantly lower than those of the nonresponders group (All P<. 05). The expansion and diastolic emptying indices of the responders group were significantly higher than those of the nonresponders group (All P<.05). The PE and PEI of the responders were significantly higher than those of the nonresponders group (All P<.05). The AE and AEI of the responders were significantly lower than those of the nonresponders group (All P<.05).Conclusions: We found an improvement in the LA reservoir and conduit function but a reduction in LA booster pump function 1 year after the SA in the responders.

Immediate and one-year follow-up outcome of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy

The Effect on Electrocardiographic and Cardiac Autonomic Function after Percutaneous Transluminal Septal Myocardial Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Acute Results and Three-Year Noninvasive Follow-Up in 18 Patients.

Influence of percutaneous transluminal septal myocardial ablation of hypertrophic obstructive cardiomyopathy on mitral regurgitation

Short-term Effect of Percutaneous Transluminal Septal Myocardium Ablation on Hypertrophic Obstructive Cardiomyopathy

Acute results of percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy

Long-term Efficiency of Percutaneous Transluminal Septal Myocardial Ablation for Treating the Patients With Hypertrophic Obstructive Cardiomyopathy

ASSA14-04-01 Long-Term Efficiency of Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstractive Cardiomyopathy

Assessment of Left Ventricular Systolic Synchrony Before and after Percutaneous Transluminal Septal Myocardial Ablation of Hypertrophic Obstructive Cardiomyopathy by Two Dimensional Speckle Tracking Imaging

ASSA14-04-02 Long-Term Efficiency of Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy

Results after Percutaneous Transluminal Septal Myocardial Ablation of Hypertrophic Obstructive Cardiomyopathy

A three-year follow-up comparative study for treating hypertrophic obstructive cardiomyopathy with percutaneous transluminal septal myocardial ablation or septal myectomy

Evaluation of efficacy and safety of percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy

Therapeutic Effects of Alcohol Septal Ablation in Mildly Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy

Selective Interventricular Septal Radiofrequency Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?

A Modified Endocardial Radiofrequency Ablation Approach for Hypertrophic Obstructive Cardiomyopathy Guided by Transthoracic Echocardiography: a Case Series

Predictive Value of Left Ventricular Endocardial Pacing in Percutaneous Transluminal Septal Myocardial Ablation of Hypertrophic Obstructive Cardiomyopathy

Assessment of Left Atrial Function in Patients with Hypertrophic Obstructive Cardiomyopathy Before and One Year after Alcohol Septal Ablation by Two Dimensional Speckle Tracking Echocardiography

Left Ventricular Endocardial Pacing Predicts the Reduction of Left Ventricular Outflow Tract Pressure Gradient Immediately after Percutaneous Transseptal Myocardial Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy Refractory to Medication.

Color Echocardiographic Investigation in Percutaneous Transluminal Septal Myocardial Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy

Value of Echocardiography in the Guidance of Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy